Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATM | Q13315 | 1/20 | 0.38 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.34 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.34 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | GRM1 | Q13255 | 4/20 | 0.32 |
| ▸ | SCN9A | Q15858 | 5/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18232620 | 1.00 | ATM (0.38) | ATMCYP19A1CYP1A2CYP2D6CYP2C9 | |
| SCHEMBL23143082 | 0.82 | ATM (0.44) | ATMCYP19A1CYP1A2CYP2D6CYP2C9 | |
| SCHEMBL16171263 | 0.76 | CYP1A2 (0.37) | CYP19A1CYP1A2CYP2D6CYP2C9CYP2C19 | |
| SCHEMBL9586910 | 0.76 | ATM (0.40) | ATMCYP19A1EPHX2POLBGRM1 | |
| SCHEMBL23140753 | 0.76 | CYP19A1 (0.48) | ATMCYP19A1CYP1A2CYP2D6CYP2C9 | |
| SCHEMBL10188098 | 0.75 | SCN9A (0.31) | ATMSCN9A | |
| SCHEMBL18775637 | 0.73 | FDFT1 (0.35) | CYP2C9EPHX2SCN9A | |
| SCHEMBL10172872 | 0.72 | POLB (0.42) | CYP1A2CYP2D6CYP2C9CYP2C19HIF1A | |
| SCHEMBL18785751 | 0.72 | ATM (0.36) | ATMCYP19A1CYP1A2CYP2D6CYP2C9 | |
| SCHEMBL14318437 | 0.72 | GRM1 (0.38) | ATMCYP19A1EPHX2GRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200369605-A1 | ONIUM SALT, CHEMICALLY AMPLIFIED RESIST COMPOSITION AND PATTERNING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2020-11-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200369605-A1 | ONIUM SALT, CHEMICALLY AMPLIFIED RESIST COMPOSITION AND PATTERNING PROCESS | PAG1, SLC6A5, LBR | ATM 4467/4885CYP19A1 4682/4885CYP1A2 4576/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.